Sophia Randolph - Jul 25, 2023 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role: Chief Medical Officer, Director
Signature: /s/ Peter Garcia, by power of attorney
Stock symbol: ALXO
Transactions as of: Jul 25, 2023
Transactions value $: $0
Form type: 4
Date filed: 7/27/2023, 04:27 PM
Previous filing: Jul 5, 2023
Next filing: Jan 3, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALXO	Common Stock	Award		+34K	+12.08%		315K	Jul 25, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALXO	Common Stock	Award	$0	+107K		$0.00	107K	Jul 25, 2023	Common Stock	107K	$5.86	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2023.
F2	Shares subject to the option vest in 48 equal monthly installments beginning on August 3, 2023.